EUVIMEDEUVIMED entdecken
Open Access

Investigation of Fat Metabolism during Antiobesity Interventions by Magnetic Resonance Imaging and Spectroscopy

Arunima Pola, Suresh Anand Sadananthan, Venkatesh Gopalan, Min-Li Sandra Tan, Terry Yew Keong, Zhihong Zhou, Seigo Ishino, Yoshihide Nakano, Masanori Watanabe, Takashi Horiguchi, Tomoyuki Nishimoto, Bin Zhu und 1 weitere

Magnetic Resonance Insights · 2014

DOI: 10.4137/mri.s19362 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Magnetic Resonance Insights, 2014. Verfasst von Arunima Pola und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Imaging, Singapore Bioimaging Consortium, ASTAR, Singapore. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The focus of current treatments for obesity is to reduce the body weight or visceral fat, which requires longer duration to show effect. In this study, we investigated the short-term changes in fat metabolism in liver, abdomen, and skeletal muscle during antiobesity interventions including Sibutramine treatment and diet restriction in obese rats using magnetic resonance imaging, magnetic resonance spectroscopy, and blood chemistry. Sibutramine is an antiobesity drug that results in weight loss by increasing satiety and energy expenditure. The Sibutramine-treated rats showed reduction of liver fat and intramyocellular lipids on day 3. The triglycerides (TG) decreased on day 1 and 3 compared to baseline (day 0). The early response/nonresponse in different fat depots will permit optimization of treatment for better clinical outcome rather than staying with a drug for longer periods.

Schlagwörter

Stichwörter der Autor:innen

MRIMRSSibutraminecalorie restrictionintramyocellular lipidsliverobesity

Autor:innen und Institutionen

  • Laboratory of Molecular Imaging, Singapore Bioimaging Consortium, ASTAR, Singapore.
  • Singapore Institute for Clinical Sciences, ASTAR, Singapore.
  • Takeda Singapore Pte. Ltd., Singapore.
  • Takeda Pharmaceutical Company Limited, Tokyo, Japan.
  • Laboratory of Molecular Imaging, Singapore Bioimaging Consortium, ASTAR, Singapore. ; Singapore Institute for Clinical Sciences, A*STAR, Singapore. ; Clinical Imaging Research Centre, NUS-A*STAR, Singapore.

Zitieren

APA

Pola, A., Sadananthan, S. A., Gopalan, V., Tan, M. L., Keong, T. Y., Zhou, Z., Ishino, S., Nakano, Y., Watanabe, M., Horiguchi, T., Nishimoto, T., Zhu, B., & Velan, S. S. (2014). Investigation of Fat Metabolism during Antiobesity Interventions by Magnetic Resonance Imaging and Spectroscopy. Magnetic Resonance Insights. https://doi.org/10.4137/mri.s19362

Vancouver

Pola A, Sadananthan SA, Gopalan V, Tan ML, Keong TY, Zhou Z, et al. Investigation of Fat Metabolism during Antiobesity Interventions by Magnetic Resonance Imaging and Spectroscopy. Magnetic Resonance Insights. 2014. doi:10.4137/mri.s19362

BibTeX
@article{Pola2014,
  author = {Pola, Arunima and Sadananthan, Suresh Anand and Gopalan, Venkatesh and Tan, Min-Li Sandra and Keong, Terry Yew and Zhou, Zhihong and Ishino, Seigo and Nakano, Yoshihide and Watanabe, Masanori and Horiguchi, Takashi and Nishimoto, Tomoyuki and Zhu, Bin and Velan, S Sendhil},
  title = {Investigation of Fat Metabolism during Antiobesity Interventions by Magnetic Resonance Imaging and Spectroscopy},
  journal = {Magnetic Resonance Insights},
  year = {2014},
  doi = {10.4137/mri.s19362}
}
Kostenlos starten →